- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intravenous immunoglobulin and Alzheimer’s disease: what now? ; volume:10 ; number:1 ; day:5 ; month:6 ; year:2013 ; pages:1-7 ; date:12.2013
Journal of neuroinflammation ; 10, Heft 1 (5.6.2013), 1-7, 12.2013
- Urheber
-
Loeffler, David A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-10-70
- URN
-
urn:nbn:de:1111-2016032334383
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loeffler, David A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer
Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer
Assessing What Matters to People Affected by Alzheimer’s Disease: A Quantitative Analysis
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Early and late-onset Alzheimer’s disease: What are the differences?
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
Alzheimer’s Disease
The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Alzheimer
Alzheimer